GALNT2 targeted by miR-139-5p promotes proliferation of clear cell renal cell carcinoma via inhibition of LATS2 activation

• Published in: Discover. Oncology Vol. 15; no. 1; p. 73
• Main Authors: Yi, Haisheng, Liu, Lingyun, Zhang, Jingshun, Guo, Kaimin, Cao, Yin, Sun, Penghao, Wang, Hongliang
• Format: Journal Article
• Language: English
• Published: New York Springer US 13-03-2024; Springer Nature B.V; Springer
• Subjects: Apoptosis; Cancer Research; Cell growth; Colorectal cancer; Cytotoxicity; Gene expression; Internal Medicine; Kidney cancer; Medical prognosis; Medicine; Medicine & Public Health; MicroRNAs; Molecular Medicine; Oncology; Polypeptides; Proteins; Radiotherapy; Surgical Oncology; Tumorigenesis; Beijing China; China
• ISSN: 2730-6011; 2730-6011
• DOI: 10.1007/s12672-024-00930-4

Polypeptide
N
-Acetylgalactosaminyltransferase (GALNTs) are critical enzymes that initiate mucin type-O glycosylation, and are closely associated with the occurrence and development of multiple cancers. However, the significance of GALNT2 in clear cell renal cell carcinoma (ccRCC) progression remains largely undetermined. Based on public multi-omics analysis, GALNT2 was strongly elevated in ccRCC versus adjoining nontumor tissues, and it displayed a relationship with poor overall survival (OS) of ccRCC patients. In addition, GALNT2 over-expression accelerated proliferation of renal cancer cell (RCC) lines. In contrast, GALNT2 knockdown using shRNAs suppressed cell proliferation, and this was rescued by LATS2 knockdown. Similarly, GALNT2 deficiency enhanced p-LATS2/LATS2 expression. LATS2 is activated by phosphorylation (p-LATS2) and, in turn, phosphorylate the downstream substrate protein YAP. Phosphorylated YAP (p-YAP) stimulated its degradation and cytoplasmic retention, as it was unable to translocate to the nucleus. This resulted in reduced cell proliferation. Subsequently, we explored the upstream miRNAs of GALNT2. Using dual luciferase reporter assay, we revealed that miR-139-5p interacted with the 3ʹ UTR of GALNT2. Low miR-139-5p expression was associated with worse ccRCC patient outcome. Based on our experiments, miR-139-5p overexpression inhibited RCC proliferation, and this phenotype was rescued by GALNT2 overexpression. Given these evidences, the miR-139-5p-GALNT2-LATS2 axis is critical for RCC proliferation, and it is an excellent candidate for a new therapeutic target in ccRCC.